廣生堂(300436.SZ):控股子公司取得不動產權證書
格隆匯5月8日丨廣生堂(300436.SZ)公佈,近日,公司控股子公司江蘇中興藥業有限公司(“江蘇中興”)取得鎮江市自然資源和規劃局頒發的《不動產權證書》,證書確權地塊是公司2020年創業板非公開發行A股股票募投項目之一“江蘇中興製劑車間建設項目”的建設用地。此次不動產權證書的取得,有助於江蘇中興製劑車間建設項目建設工作順利推進,滿足了其未來發展對自有經營場地的需求。
證書編號:32012835279;產證號:蘇(2020)鎮江市不動產權第0017887號;權利人:江蘇中興藥業有限公司共有情況:單獨所有;坐落:鎮江市丹徒區丹楓路以南宜夏路以西;不動產單元號:321112036206GB00050W00000000;權利類型:國有建設用地使用權;權利性質:出讓;用途:工業用地;面積:24042.0m2;使用期限:至2069年03月06日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.